Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheum with a View

Richard S. Panush, MD  |  Issue: August 2011  |  August 1, 2011

Let me tell you my thoughts about cell phones and driving, dining, and certain other personal and interpersonal activities. Now I try to turn a bit serious. We have a couple of observations showing that, under some circumstances, cell phones have a biological effect—on bone and brain, in these studies. Some have enough concern about the relationship to gliomas to consider the risk in the 2B category (possible carcinogen).

Am I an alarmist? Am I some wide-eyed, bearded radical? Not at all. Not my style. Do I think we are going to have an epidemic of serious health problems from cell phones? Not really. But stranger things have happened. We used to treat acne with irradiation, ankylosing spondylitis with irradiation, certain pregnant women with diethyl stilbesterol, and anxious patients with thalidomide, all of which led to delayed-onset, unexpected, horrible tragedies. Did you or your parents ever buy a Corvair (which was “unsafe at any speed”)? And I’m sure you can think of other products, or even social or medical trends, introduced only for their “adverse effects to be discovered later.” It’s not impossible.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

I really am not a “technophobe” or luddite. In the lab, I participate in some incredibly sophisticated, technologically advanced experiments. I think first I’ll examine the effects of cell phone electromagnetic fields on mediator release in vitro (how much do you want to bet I’ll find something, for some cytokine, in some circumstance?). Then I’ll move on to experimental arthritis in animals (double or nothing?). And next I think I should be ready for fibromyalgia patients in the clinic (this will surely lead to fame and fortune).

My dogs, by the way, seem not to have suffered any ill effects from eating my cell phone.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Don’t call me, I’ll call you.

*Some of the style used in this column, particularly the use of strike-through text for comic effect, was derived from “The Life of Reilly” feature, by Rick Reilly, in Sports Illustrated, particularly that of May 17, 1999.

Dr. Panush is professor of medicine, Division of Rheumatology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles.

References

  1. Volkow ND, Tomasi D, Want G-J, et al. Effects of cell phone radiofrequency signal exposure on brain glucose metabolism. JAMA. 2011;305:808-81.
  2. Lai H, Hardell L. Cell phone radiofrequency radiation exposure and brain glucose metabolism. JAMA. 2011;305:828-829.
  3. Mukherjee S. Do cellphones cause brain cancer? New York Times Magazine, April 13, 2011;pp. 29, 32, 34-36, 65.
  4. Horwitz LI, Detsky AS. Physician communication in the 21st century: To talk or to text? JAMA. 2011;305:1128-1129.
  5. Saravi FD. Asymmetries in hip mineralization in mobile cellular phone users. J Craniofac Surg. 2011;22:706-710.
  6. International Agency for Research on Cancer. World Health Organization. IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans. May 31, 2011, pp. 1-6.
  7. Rheumatology Morning Wire, June 1, 2011.
  8. American Cancer Society. Cellular Phones. Available at www.cancer.org/cancer/cancercauses/othercarcinogens/athome/cellular-phones. Updated May 31, 2011. Accessed July 15, 2011.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ProfilesResearch RheumTechnology Tagged with:ArthritisCancerResearchriskTechnology

Related Articles

    Tech Talk: Physicians Debate Using Cell Phones to Communicate with Patients

    November 1, 2013

    Concerns about protecting personal privacy and receiving after-hours calls are balanced by physicians’ desire to connect with patients

    The Brain in Lupus

    September 1, 2008

    The Mary Kirkland Center lupus conference offers insight into cognitive aspects of SLE

    Chronic Pain Research Probes Neurologic Pain Pathways, Biomarkers

    February 18, 2018

    With the aid of increasingly sophisticated neuroimaging technology, research into how the brain activates and changes in patients with chronic pain is delivering fascinating information that will hopefully pave the way to tailored, individual treatment of chronic pain. Over the past several years, data from neuroimaging studies have provided a new understanding of what occurs…

    Lightspring/shutterstock.com

    The Immune Checkpoint Inhibitors Unleashed to Fight Cancer

    May 17, 2017

    A 53-year-old female presented to the clinic for severe polyarticular joint pain and was found to have a seronegative inflammatory arthritis. Six months before, she had completed 10 months of treatment for stage IV metastatic melanoma with the immune checkpoint inhibitors, nivolumab and ipilimumab, achieving complete remission of her cancer. She said that throughout her…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences